Highlights in Metastatic Breast Cancer from the 2022 San Antonio Breast Cancer Symposium

A Review of Selected Presentations from SABCS 2022 • San Antonio, TX  •  December 6-10, 2022 EMERALD Phase 3 Trial of Elacestrant Versus Standard of Care […]

Progress in the Treatment of Breast Cancer: Increased Survival, Improved Patient Experience, and Advances in Drug Formulation

A Review of Selected Presentations From the 2022 San Antonio Breast Cancer Symposium® • December 6-11, 2022  •  San Antonio, Texas  Sacituzumab Govitecan vs Treatment of […]

Highlights in Chronic Lymphocytic Leukemia from the 64th American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations from ASH 2022 December 10-13, 2022  •  New Orleans, Louisiana Combination of Ibrutinib Plus Venetoclax with MRD-Driven Duration of Treatment Results […]

Back to Archive